GGrantIndex
Sort

166,118 grants matching stem cells

A New Disease Platform Leveraging Complex Drosophila and Mammalian Models

$1,987,779
Ross Leigh Cagan · Icahn School Of Medicine At Mount Sinai · U54 · FY2016 · OD

COBRE in Stem Cell Biology and Regenerative Medicine

$1,987,665
Don Wojchowski · Mainehealth · P20 · FY2012 · GM

YALE COMPREHENSIVE CANCER CENTER

$1,987,599
Yale University · P30 · FY2000 · CA

A New Disease Platform Leveraging Complex Drosophila and Mammalian Models

$1,987,420
Ross Leigh Cagan · Icahn School Of Medicine At Mount Sinai · U54 · FY2019 · OD

The Epigenetic Landscape of Heart Development

$1,987,290
Benoit Gaetan Bruneau · J. David Gladstone Institutes · U01 · FY2011 · HL

1/2 Genomic Strategies to Identify High-impact Psychiatric Risk Variants

$1,986,913
Nelson B Freimer · University Of California Los Angeles · U01 · FY2017 · MH

Exploring Design Principles of Cellular Control Circuits

$1,986,405
Wendell A Lim · University Of California, San Francisco · P50 · FY2016 · GM

Blood Stem Cell Transplantation as Immunotherapy

$1,985,980
Stanford University · P01 · FY2005 · HL

Development of a Universal Assay for Minimal Residual Disease in Acute Myeloid Leukemia using Duplex Sequencing

$1,985,831
Kellie Bickel · Twinstrand Biosciences, Inc. · R44 · FY2025 · CA

Pathophysiology and Treatment of Fanconi Anemia

$1,985,543
Markus Grompe · Oregon Health & Science University · P01 · FY2018 · HL

Mixed Hematopoietic Chimerism after Stem Cell Allografts

$1,985,492
Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2007 · CA

Preclinical Toxicology & Pharmacology of Drugs Developed for Cancer

$1,985,380
James E. Estep · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2010 · CA

Development And Regulation Of The Gonadotropin Releasing Hormone System

$1,985,351
Susan Wray · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS

Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy

$1,985,262
Daniel Fowler · Clinical Sciences · Z01 · FY2007 · CA

Dietary Restriction, GH/IGF-1 & Mechanisms of Cellular Protection and Regeneration

$1,985,236
Valter D. Longo · University Of Southern California · P01 · FY2022 · AG

Mapping the vulnerable locus coeruleus pathways in aging and AD

$1,984,794
Kwanghun Chung · Massachusetts Institute Of Technology · U01 · FY2022 · AG

Transgenic resources for neuroscience research

$1,984,775
James Pickel · National Institute Of Mental Health · ZIC · FY2014 · MH

IGF::OT::IGF R&D- NANOEMULSION FORMULATION AND IND-ENABLING STUDIES OF A NOVEL CENTER STEM CELL CYTOTOXIC AGENT

$1,984,617
James Egan · Targagenix, Inc. · N44 · FY2016 · CA

Genes and signals controlling mammalian hematopoiesis.

$1,984,290
Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD

A NOVEL NUCLEAR COUNTERMEASURE TARGETING ENDOTHELIAL CELLS AND STEM CELLSTO COMBAT ARS AND DELAYED MULTIPLE ORGAN DYSFUNCTION

$1,984,084
Laurie Sower · Chrysalis Biotherapeutics, Inc. · N01 · FY2018 · AI

A Phase 2b Clinical Trial to Study the Efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) to Treat Aging Frailty

$1,983,531
Anthony Andrew Oliva · Longeveron, Llc · R44 · FY2019 · AG

Systematically mapping variant effects for cardiovascular genes

$1,983,411
Dan M Roden · Vanderbilt University Medical Center · R01 · FY2024 · HL

Impact of FGF21 on healthspan and lifespan

$1,983,293
Vishwa Deep Dixit · Yale University · P01 · FY2020 · AG

Developmental origins of mental illness: evolution and reversibility

$1,983,261
Takao K Hensch · Harvard University · P50 · FY2019 · MH

Developmental origins of mental illness: evolution and reversibility

$1,983,261
Takao K Hensch · Harvard University · P50 · FY2020 · MH